Clinical Trial Update: A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial registry entry describes a first-in-human dose-escalation and dose-expansion Phase 1/2 study of SAR445877 in adults with advanced solid tumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• SAR445877 (SAR445877)

Snippet

Sponsor: Sanofi | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING